NCT07707349

Brief Summary

Dental fluorosis is a developmental enamel defect characterized by discoloration and altered enamel appearance, which may negatively affect dental esthetics and patient satisfaction. Conservative treatment approaches, including enamel microabrasion and minimally invasive chemical treatments, have been proposed to improve the appearance of affected teeth while preserving tooth structure. However, evidence comparing the effectiveness of these treatment modalities remains limited. This randomized controlled clinical trial aims to compare the effectiveness of Antivet treatment and Opalustre enamel microabrasion in improving the esthetic appearance of mild enamel fluorosis/discolored enamel affecting anterior teeth. Eligible participants with mild enamel fluorosis will be randomly allocated to receive either Antivet treatment or Opalustre enamel microabrasion in a 1:1 ratio. Tooth color will be objectively assessed before and after treatment using a spectrophotometer based on the CIELAB color system (L\*, a\*, and b\* coordinates), and the overall color difference (ΔE) will be calculated. The primary outcome is the change in tooth color following treatment, while secondary outcomes include changes in individual CIELAB color coordinates. The findings of this study are expected to provide evidence regarding the comparative effectiveness of these minimally invasive treatment modalities for the esthetic management of mild enamel fluorosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2026

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
Last Updated

July 16, 2026

Status Verified

May 1, 2026

Enrollment Period

28 days

First QC Date

July 9, 2026

Last Update Submit

July 15, 2026

Conditions

Keywords

Enamel FluorosisEnamel discolorationAntivetOpalustureMicro abrasionSpectrophotometer

Outcome Measures

Primary Outcomes (1)

  • The mean change in color

    The primary outcome measure was the change in tooth color following treatment, objectively assessed using a spectrophotometer based on the Commission Internationale de l'Éclairage (CIELAB) color system. Color coordinates (L\*, a\*, and b\*) were recorded at the base line and then after the intervention was applied in the same visit and the overall color difference (ΔE) was calculated to quantify treatment-induced color improvement.

    Baseline (before treatment) and immediately after completion of the intervention (same visit Day 1).

Study Arms (2)

Antivet

EXPERIMENTAL
Other: Antivet

Opalusture microabrasion

ACTIVE COMPARATOR
Other: Opalusture

Interventions

AntivetOTHER

Microabrasion

Antivet

Enamel Micro abrasion

Opalusture microabrasion

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged from 20-35 years old.
  • Patients free from any systematic diseases.
  • Patients agreed to the informed consent and are compliant to the follow-up periods.
  • Teenagers and young adult patients refrained from tobacco products throughout the current study period.
  • Patients with hypominerlized maxillary and mandibular ante- rior teeth (incisors and canines) were included.
  • Teeth with Degree 1 (mild) according to the Wetzel and Reckel scale.

You may not qualify if:

  • Patients with special health care needs or any systemic disease that may delay normal healing.
  • Patients having bad oral hygiene.
  • Patients who could not be committed to the follow-up period.
  • Patients suffering from untreated, periodontal diseases
  • Participants with caries lesions or defective restorations in the anterior teeth.
  • Sensitive and fractured teeth.
  • Participants who had a history of dental bleaching.
  • Patients participating in other dental studies.
  • Patients suffering from hypoplasia, amelogenesis imperfecta, dentinogenesis imperfecta, tetracycline stains, fluorosis, or badly broken and missing teeth due to MIH.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October University for Modern Sciences and Arts

Giza, Sixth of October, 12566, Egypt

Location

Related Publications (2)

  • 10.21608/edj.2023.217606.2603

    RESULT
  • Diab DFS, Elhaddad EEH. Comparative effect of Antivet(R), Oplasture(R), and a prototype paste on color change and microhardness of simulated stained enamel: an in vitro study. BDJ Open. 2025 Dec 30;11(1):100. doi: 10.1038/s41405-025-00393-x.

MeSH Terms

Conditions

Fluorosis, Dental

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Due to the nature of the interventions, operator blinding was not feasible. However, the examiner responsible for outcome assessment and the biostatistician performing the statistical analyses were blinded to treatment allocation throughout the study to minimize detection and analysis bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants meeting the eligibility criteria were randomly assigned in a 1:1 allocation ratio to one of two parallel treatment groups. The intervention group received Antivet treatment, while the control group underwent enamel microabrasion using Opalustre. Each participant received only one of the two interventions, and treatment allocation remained unchanged throughout the study. The effectiveness of both treatment modalities was evaluated by comparing changes in tooth color before and after treatment using objective spectrophotometric measurements based on the CIELAB color system.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Conservative Dentistry

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 16, 2026

Study Start

May 18, 2026

Primary Completion

June 15, 2026

Study Completion

July 7, 2026

Last Updated

July 16, 2026

Record last verified: 2026-05

Locations